HomeNews

News

Research Spotlight: Alzheimer’s Disease

June is Alzheimer’s & Brain Awareness Month. We wanted to take a few moments to spotlight some of the awe-inspiring research on Alzheimer’s disease taking place in alternative animal models: C. elegans: Kumar DK, Choi SH, Washicosky KJ, et al. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci …

Research Spotlight: Alzheimer’s Disease Read More »

InVivo Biosystems has partnered with Enviral Tech to help you safely return to lab

Information about the COVID-19 virus (SARS-CoV-2) is constantly changing. This leaves essential business and healthcare facilities scrambling to find ways to ensure their employees, customers’ and patients’ safety. It is crucial to know if and when the virus has infiltrated a facility in order to minimize the impact that it could have. Now that non-essential …

InVivo Biosystems has partnered with Enviral Tech to help you safely return to lab Read More »

FAVOR Grant

New NIH Grant awarded to InVivo Biosystems to address critical needs in precision medicine research

New NIH Grant awarded to InVivo Biosystems to address critical needs in precision medicine research using the model of C. elegans. The grant, titled “Functional Assessment of Variants in Organisms of Research (FAVOR) – Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping” in the amount of $350,000 is awared by the Nation Human Genome Research Institute (NHGRI).

Read More »

[Webinar] A Shortcut To Understanding Longevity: A Rapid In Vivo Analysis Of A Compound’s Effect On Health And Aging

Learn more about our Longevity Platform and how it can benefit you by tuning into our recent webinar! Title: A Shortcut to Understanding Longevity: A Rapid in vivo Analysis of a Compound’s Effect on Health and Aging Agenda: Who are we? Healthy Aging: compounds for improving longevity and healthspan Nutraceutical market drivers and pain points InVivo …

[Webinar] A Shortcut To Understanding Longevity: A Rapid In Vivo Analysis Of A Compound’s Effect On Health And Aging Read More »

NemaMetrix Expands Business to Capitalize on In-vivo Solutions to Help Speed Testing for Critical Disease Therapeutics

Company Changes Operating Name to InVivo Biosystems Eugene, Ore. – March 31, 2020 – NemaMetrix is changing its operating name to InVivo Biosystems as the company expands its research platforms to accelerate deep in-vivo insights that help researchers develop and deliver therapeutic solutions for critical diseases. The company’s solutions now provide essential services to pharmaceutical, …

NemaMetrix Expands Business to Capitalize on In-vivo Solutions to Help Speed Testing for Critical Disease Therapeutics Read More »

COVID-19 UPDATE: Current Offerings/How can we help your lab?

Impacted by COVID-19? We are here for you and ready to help We have received reports from some of our customers that the closures at their institutions due to the COVID-19 pandemic are causing disruptions in their work. While it is not completely “business as usual” for our company, we have resources in place to provide you …

COVID-19 UPDATE: Current Offerings/How can we help your lab? Read More »

Continuity of business in response to COVID-19

As the situation regarding the COVID-19 outbreak changes daily, we wanted to advise you on how we are addressing the issue at InVivo Biosystems. Our top priorities are the health and safety of our employees and ensuring that our customer’s project can continue uninterrupted. This effort starts with our internal readiness efforts. Internal teams have …

Continuity of business in response to COVID-19 Read More »

NemaMetrix raises $5 million USD funding and strengthens senior team

  Investment will be used to further develop the Company’s Precisome platform for functional analysis New investment led by Oregon Venture Fund Dr Stephen Turner appointed as Senior Research Fellow to help lead company expansion   Eugene, Oregon, USA, 29 July 2019: NemaMetrix, an Oregon-based company that provides phenotyping and functional analysis using C. elegans …

NemaMetrix raises $5 million USD funding and strengthens senior team Read More »

New Milestone! We can now remove over 43,000 bp from C. elegans genomic DNA!

12k, 24k, 36k…we can now precisely remove over 43k bp from C. elegans genomic DNA! Knocking out genes is a commonly used tool for biologists to understand gene function in live animals. The examination of phenotypes when a gene is deleted can reveal valuable insights into what role that gene plays in the organism and …

New Milestone! We can now remove over 43,000 bp from C. elegans genomic DNA! Read More »

Scroll to Top